MX353876B - Metodo para el tratamiento de una infeccion. - Google Patents

Metodo para el tratamiento de una infeccion.

Info

Publication number
MX353876B
MX353876B MX2013008407A MX2013008407A MX353876B MX 353876 B MX353876 B MX 353876B MX 2013008407 A MX2013008407 A MX 2013008407A MX 2013008407 A MX2013008407 A MX 2013008407A MX 353876 B MX353876 B MX 353876B
Authority
MX
Mexico
Prior art keywords
antibiotic
nsaid
aqueous solvent
mastitis
injectable compositions
Prior art date
Application number
MX2013008407A
Other languages
English (en)
Other versions
MX2013008407A (es
Inventor
Al Alawi Fadil
Frederick Leech Wayne
Nanjan Karthigeyan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46515931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX353876(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of MX2013008407A publication Critical patent/MX2013008407A/es
Publication of MX353876B publication Critical patent/MX353876B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto inyectable cuando se utiliza para el tratamiento de una infección microbiana en una glándula mamaria de un animal, en el que el compuesto incluye a) un fármaco antinflamatorio no esteroide (AINE); b) un antibiótico seleccionado del grupo de antibiótico betalactámico y un antibiótico macrólido; caracterizado porque el compuesto incluye un disolvente no acuoso, y el AINE y el antibiótico en el compuesto se disuelven en el disolvente no acuoso.
MX2013008407A 2011-01-20 2012-01-20 Metodo para el tratamiento de una infeccion. MX353876B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ588686A NZ588686A (en) 2011-01-20 2011-01-20 Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
PCT/NZ2012/000003 WO2012099479A1 (en) 2011-01-20 2012-01-20 Injectable compositions for mastitis comprising an nsaid and an antibiotic in a non-aqueous solvent

Publications (2)

Publication Number Publication Date
MX2013008407A MX2013008407A (es) 2013-09-26
MX353876B true MX353876B (es) 2018-02-01

Family

ID=46515931

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008407A MX353876B (es) 2011-01-20 2012-01-20 Metodo para el tratamiento de una infeccion.

Country Status (15)

Country Link
KR (1) KR101905173B1 (es)
CN (1) CN103327984B (es)
AU (1) AU2012207698A1 (es)
BR (1) BR112013018557B1 (es)
CL (1) CL2013002086A1 (es)
CO (1) CO6801732A2 (es)
CR (1) CR20130401A (es)
GT (1) GT201300182A (es)
IL (1) IL227540A (es)
MX (1) MX353876B (es)
NI (1) NI201300063A (es)
NZ (1) NZ588686A (es)
PE (1) PE20140035A1 (es)
WO (1) WO2012099479A1 (es)
ZA (1) ZA201305780B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2995297A1 (fr) * 2014-09-09 2016-03-16 Ceva Sante Animale Compositions parentérales et leurs utilisations
AR102172A1 (es) * 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida
CN105663037A (zh) * 2016-01-27 2016-06-15 成都乾坤动物药业有限公司 一种阿莫西林溶液剂及其制备方法和用途
CN112472667B (zh) * 2019-08-23 2022-11-15 北京欧博方医药科技有限公司 一种维他昔布长效注射液及其制备方法和应用
CN111035614B (zh) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 一种高含量土霉素注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CN1297319C (zh) * 2003-09-22 2007-01-31 王玉万 以硅油为介质制备含抗微生物药物的制剂
US20050148519A1 (en) * 2003-10-29 2005-07-07 Murthy Yerramilli V.S. Salts of pharmacologically active compounds
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung

Also Published As

Publication number Publication date
KR101905173B1 (ko) 2018-11-28
BR112013018557B1 (pt) 2021-11-03
WO2012099479A1 (en) 2012-07-26
NI201300063A (es) 2014-05-23
NZ588686A (en) 2013-07-26
GT201300182A (es) 2014-07-28
CN103327984B (zh) 2016-08-17
IL227540A (en) 2017-12-31
CN103327984A (zh) 2013-09-25
PE20140035A1 (es) 2014-02-16
BR112013018557A2 (pt) 2016-11-22
MX2013008407A (es) 2013-09-26
CL2013002086A1 (es) 2014-07-25
ZA201305780B (en) 2014-04-30
AU2012207698A1 (en) 2013-04-18
IL227540A0 (en) 2013-09-30
KR20140012646A (ko) 2014-02-03
CR20130401A (es) 2014-02-04
CO6801732A2 (es) 2013-11-29

Similar Documents

Publication Publication Date Title
EP3895717A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE SUBSTANCE
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
CL2014000468A1 (es) Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana.
EA201000774A1 (ru) Ингибиторы бета-лактамазы
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
CL2017003325A1 (es) Derivados de 3-tetrazolilo-benceno-1,2-disulfonamida como inhibidores de metalo-beta-lactamasa
IL231358A (en) Topical veterinary preparations containing active isoxazoline for the treatment or prevention of infection or parasitic spread
BR112017011478A2 (pt) composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante
DK3061454T3 (da) Parasitiske orale veterinærsammensætninger omfattende systemisk-virkende aktivstoffer, fremgangsmåder og anvendelser deraf
MX356926B (es) Formulación de isoxazolina tópica localizada.
PH12014502441A1 (en) Topical non-aqueous pharmaceutical formulations
MX353876B (es) Metodo para el tratamiento de una infeccion.
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
MX2011008043A (es) Derivados de actagardina.
BR112014025041B8 (pt) Composição farmacêutica
WO2014179567A3 (en) Methods and compositions for treating beta-thalassemia and sickle cell disease
MX2015003164A (es) Formulaciones de daptomicina y usos de la misma.
MX2014006601A (es) Formulaciones de moxidectina inyectables de larga accion y formas de cristal de moxidectina novedosas.
EP3689333A4 (en) LOCAL INJECTION SOLUTION WITH TWO MEDICINAL PRODUCTS FOR SUBMUCOSAL INJECTION
PH12018502105A1 (en) Use of amino sugar as plasticizer
MY164916A (en) Ectoparasiticidal active substance combinations
IN2013MU01985A (es)
EP4005614A4 (en) DRUG SOLUTION INJECTION DEVICE
MY184630A (en) Tylosin derivatives and method for preparation thereof
PH12014501384A1 (en) Antibiotic formulations

Legal Events

Date Code Title Description
FG Grant or registration